University of California, San Francisco
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Francisco sits in the top decile of US sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count).
University of California, San Francisco: 1,713 sponsored US clinical trials, 272 recruiting.
University of California, San Francisco sponsors 1,713 registered US clinical trials on ClinicalTrials.gov, 272 of them currently recruiting, and 1,130 completed. 196 of these trials are in Phase 3-4 (later-stage) and 359 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 18 trials.
Top-decile sponsor footprint
University of California, San Francisco ranks in the top decile of sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,130 of 1,305 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,713 total, page 8 of 35
Insulin Resistance in HCV Infection
NCT01858012
Genetic Epidemiology of Ovarian Aging
NCT00501800
Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer
NCT00769223
Human-centered Injury Thrivorship Pathway for Survivors of Physical Trauma
NCT06292039
Improv Music Therapy for Older Adults
NCT07419022
Targeting Interferon Gamma With Emapalumab to Lung Transplant Recipients With Interferon Gamma-high Acute Lung Allograft Dysfunction
NCT07538336
Antibiotics for Kidney Transplant Recipients
NCT07106125
Naloxone for Opioid Associated Out of Hospital Cardiac Arrest
NCT06251609
Real-Time Acute Kidney Injury Perioperative Prediction Clinical Trial
NCT07604662
Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma
NCT07110233
Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy
NCT06065670
Intervention for Hearing Health Among Native Americans
NCT07534098
Pilot Study of an Adapted Partner Navigation Intervention Booster Session for Sustained Healthcare Engagement Among People Who Inject Drugs
NCT07631559
CBITS-RTM Pilot Study
NCT07682441
The Social Needs Assistance for Hospitalized Kids Trial
NCT07687238
UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations
NCT06895681
Isotretinoin vs. Doxycycline for Acneiform Rash in Patients Receiving Drugs That Target the MAPK Pathway
NCT07629167
Litter Packaging in the Lateral Position: Effects of Position and Vacuum Mattress Packaging on Pulmonary Function
NCT07644793
Generative AI Patient Education Module for Breast Oncology
NCT07512271
Pulsed Electric Field Ablation for Metastatic Breast Cancer
NCT07487844
Multi-site Feasibility of an Integrated Treatment for the Biology and Experience of Depression: The MULTIBED Study
NCT07596914
Utilize Imaging to Assess Changes in Hepatocellular Carcinoma Perfusion as Potentiated by Intra-Arterial Nitroglycerin
NCT07682454
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
NCT07352566
Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote Monitoring
NCT07673237
Effect of Vision Centers on Access to Eye Care and Eye Health Outcomes
NCT07227714
Short Interval Postoperative Stereotactic Body Radiation Therapy (SBRT) After Surgical Intervention for Spine Metastases
NCT07346170
Exercise-based Frailty Intervention in Lung Transplantation (XFIT)
NCT06960421
Evaluating the Impact of CONNECT in a Multilingual Population
NCT07111936
Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II
NCT07513623
Upadacitinib in Patients Hospitalized With Acute Severe Ulcerative Colitis
NCT07502339
Short-term Effects of Methamphetamine on Residual Latent HIV Disease Study
NCT07584369
Pilot Exploration of Platelet Characterization of Platelet Rich Plasma Created by Two Different Systems
NCT07491367
Music Therapy for Oral Mucositis Pain in Pediatric Patients
NCT07653360
Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer
NCT07226466
kTMP in Chronic Stroke
NCT07277595
Indomethacin for Biliary ERCP Patients
NCT07661498
Pilot Study of Patient Navigation for Kidney Stone Patients After ED Visits
NCT07322172
The Impact of Dietary Salt on the Severity of Eczema
NCT07447063
The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
NCT07487831
Stimulant and Polysubstance Use, Inflammation, and Sex Effects on Myocardial Disease in HIV
NCT07461350
Quality of Life for Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease
NCT07659652
CHEER Oral Health in Pregnancy Study
NCT07377344
CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial
NCT06949800
Comparing Outpatient Treatment Retention Among Individuals Using Fentanyl Randomized to Low-dose and Direct-to-inject Buprenorphine Initiation
NCT07469501
Evaluation of Arts-Based Storytelling Program in Adolescents With Diabetes
NCT07625254
Preoperative Outreach to Improve Surgical Attendance
NCT07644819
UCSF Center for Genome Surgery Biobank and Registry
NCT07396285
An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service
NCT07296770
Coaching, Learning, Empowerment in Cerebral Palsy - a 6-Week Integrated PT/OT Caregiver "Primer" Bootcamp for Infants Diagnosed With or at High Risk for Cerebral Palsy
NCT07469514
Prehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis
NCT07029243
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 166 |
| Phase 3 | 44 |
| Phase 4 | 152 |
Therapeutic Areas
What is open in the University of California, San Francisco pipeline
272 recruiting of 1,713 indexed (16% open); 1,130 completed (66%).
Phase mix: 196 late (III/IV) vs 359 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (18 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Francisco: open-pipeline peers nationwide
Peers matched on 1,713 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of California, San Francisco sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,713 trials (± recruiting share)
- Duke University · 1,725 trials · 11% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 16% open enrollment (± trial volume)
- University of Oregon · 16% recruiting · 63 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- Youngstown State University · 16% recruiting · 19 trials
- ECOG-ACRIN Cancer Research Group · 16% recruiting · 75 trials
Related
What to do with this University of California, San Francisco page
1,713 registered trials is a research-attention snapshot, not an endorsement of University of California, San Francisco or any single study.
- 272 of University of California, San Francisco's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition University of California, San Francisco studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of California, San Francisco pipeline card: 1,713 registered trials from official public datasets.Report a data error.